Sign in
Latest News
Pharmaceuticals
BioPharma
MedTech
B2B News
Healthcare
Health Insurance
Nutrition & Wellness
Agro-Pharma
Animal Health
Reviews
Regulations
Product Reviews
Service Reviews
About Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Sunday, September 8, 2024
Sign in / Join
Latest News
Pharmaceuticals
BioPharma
MedTech
B2B News
Healthcare
Health Insurance
Nutrition & Wellness
Agro-Pharma
Animal Health
Reviews
Regulations
Product Reviews
Service Reviews
About Us
Facebook
Instagram
Twitter
Vimeo
Youtube
Latest News
Pharmaceuticals
BioPharma
MedTech
B2B News
Healthcare
Health Insurance
Nutrition & Wellness
Agro-Pharma
Animal Health
Reviews
Regulations
Product Reviews
Service Reviews
About Us
Search
LATEST ARTICLES
Animal Health
Impact of the Pharma Market Crash
propharmanews
-
August 7, 2024
0
Pharmaceuticals
Brain Parasites: A New Frontier in Treating Cognitive Disorders
propharmanews
-
August 7, 2024
0
B2B
The Latest on Pfizer’s $4B Cost Cutting Strategy
propharmanews
-
July 31, 2024
0
US FDA Flags Weight-Loss Overdosing Risks
propharmanews
-
July 29, 2024
0
How Ageing Reveal Early Neurodegenerative Signs? Insights from KCL
propharmanews
-
July 26, 2024
0
Moderna Co-founder Robert Langer Steps Down
propharmanews
-
July 24, 2024
0
Daily Dose Newsletter
propharmanews
-
July 19, 2024
0
Banks Plan €6 Billion Debt Financing for Sanofi Consumer Sale
propharmanews
-
July 16, 2024
0
Biotech Investor Behind Moderna Raises $3.6 Billion
propharmanews
-
July 16, 2024
0
Big Pharma Faces $183B Patent Cliff
propharmanews
-
July 16, 2024
0
1
...
3
4
5
...
17
Page 4 of 17
Most Popular
Regulatory Update — Week of Sept. 2, 2024
September 7, 2024
Judge orders J&J to pay Auris investors more than $1B for merger violations
September 7, 2024
Cloud moment – PharmaTimes
September 6, 2024
European Commission grants orphan drug designation for Vivet’s VTX-806
September 6, 2024
Load more
Recent Comments
AstraZeneca $20Bn Strategy - Pro Pharma News
on
Summit Therapeutics & AstraZeneca Shine at Major Cancer conference
China’s Generic Ozempic - Pro Pharma News
on
Ozempic’s Growing Generic Competition
Recent Comments